Year in review · from our October 2026 register copy
NAFDAC registrations in 2019
By the approval dates our October 2026 copy of the Greenbook records, 972 products were approved onto the register in 2019 — 955 of them in Drugs. 0% of the class of 2019 is still active in our copy today.
By category
- Drugs— 955
- Herbals and Nutraceuticals— 6
- Medical devices— 6
- Vaccines and Biologics— 4
- Veterinary— 1
Month by month
Approvals are batched — quiet months and spikes are the register's own rhythm, not demand.
Who registered the most
- 1.Ecomed Pharma— 21 approvals
- 2.Phillips Pharmaceuticals (Nigeria)— 21 approvals
- 3.Pal Pharmaceutical Industries— 18 approvals
- 4.TAH Pharmaceuticals— 16 approvals
- 5.Evans Baroque— 15 approvals
- 6.Hetero Labs Nigeria— 14 approvals
- 7.Onifam Laboratories— 14 approvals
- 8.Richygold International— 13 approvals
- 9.Gauze Pharmaceutical and Laboratories Nigeria— 12 approvals
- 10.Drugfield Pharmaceuticals— 11 approvals
Where the year's medicines were made
Factory countries recorded on 955 of the year's 955 drug approvals.
Month-to-month changes — new listings, renewals, lapses — live on the NAFDAC Registry Watch, updated with every register refresh.
Other years
Counted from the approval dates in our dated copy of the public NAFDAC Greenbook. The register backfills approval entries long after the fact, so a year's count can still grow after it ends — which is also why the current year has no page until it completes. Registration counts are not market share or sales.